SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199) EPS (Diluted): ¥0.09 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920199 SiChuan Qian Li Beoka Medical Technology Co Ltd BJSE:920199
57 GF Score
Price ¥27.12
GF Value ¥17.98
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is SiChuan Qian Li Beoka Medical Technology Co EPS (Diluted)?

SiChuan Qian Li Beoka Medical Technology Co BJSE:920199 57 EPS (Diluted) is ¥0.09 as of Mar. 2026. GuruFocus rates BJSE:920199 with a GF Score™ of 57/100 and a GF Value™ of ¥17.98 (Significantly Overvalued). The stock has 7 warning signs investors should review.

SiChuan Qian Li Beoka Medical Technology Co's Earnings per Share (Diluted) for the three months ended in Mar. 2026 was ¥0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.09.

SiChuan Qian Li Beoka Medical Technology Co's EPS (Basic) for the three months ended in Mar. 2026 was ¥0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.09.

SiChuan Qian Li Beoka Medical Technology Co's EPS without NRI for the three months ended in Mar. 2026 was ¥0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.10.

During the past 12 months, SiChuan Qian Li Beoka Medical Technology Co's average EPS without NRIGrowth Rate was -67.00% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -61.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was -39.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 12 years, SiChuan Qian Li Beoka Medical Technology Co's highest 3-Year average EPS without NRI Growth Rate was 149.10% per year. The lowest was -61.10% per year. And the median was 16.05% per year.


SiChuan Qian Li Beoka Medical Technology Co  (BJSE:920199) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


SiChuan Qian Li Beoka Medical Technology Co EPS (Diluted) Related Terms


SiChuan Qian Li Beoka Medical Technology Co EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for SiChuan Qian Li Beoka Medical Technology Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SiChuan Qian Li Beoka Medical Technology Co EPS (Diluted) Chart

SiChuan Qian Li Beoka Medical Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.57 1.83 0.64 0.41 0.06

SiChuan Qian Li Beoka Medical Technology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.07 0.15 0.01 0.01

BJSE:920199 vs ABT, SYK, MDT: EPS (Diluted) Comparison

For the Medical Devices subindustry, SiChuan Qian Li Beoka Medical Technology Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SiChuan Qian Li Beoka Medical Technology Co PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SiChuan Qian Li Beoka Medical Technology Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where SiChuan Qian Li Beoka Medical Technology Co's PE Ratio falls into.


BJSE:920199
57GF Score
SiChuan Qian Li Beoka Medical Technology Co Ltd BJSE:920199
EPS (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SiChuan Qian Li Beoka Medical Technology Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

SiChuan Qian Li Beoka Medical Technology Co's Diluted EPS for the fiscal year that ended in Dec. 2025 is calculated as

Diluted EPS (A: Dec. 2025 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(3.972-0)/68.132
=0.06

SiChuan Qian Li Beoka Medical Technology Co's Diluted EPS for the quarter that ended in Mar. 2026 is calculated as

Diluted EPS (Q: Mar. 2026 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(0.546-0)/68.267
=0.01

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of ¥0.09 mean?
SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199) has a EPS (Diluted) of ¥0.09 as of Mar. 2026. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on SiChuan Qian Li Beoka Medical Technology Co and its competitors.
Is SiChuan Qian Li Beoka Medical Technology Co's EPS (Diluted) too high?
SiChuan Qian Li Beoka Medical Technology Co's current EPS (Diluted) is ¥0.09. Overall, SiChuan Qian Li Beoka Medical Technology Co has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SiChuan Qian Li Beoka Medical Technology Co's EPS (Diluted) compare to ABT and SYK?
SiChuan Qian Li Beoka Medical Technology Co's EPS (Diluted) of ¥0.09 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Medical Devices & Instruments company?
A good EPS (Diluted) depends on the Medical Devices & Instruments industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on SiChuan Qian Li Beoka Medical Technology Co and its competitors. SiChuan Qian Li Beoka Medical Technology Co's current EPS (Diluted) is ¥0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SiChuan Qian Li Beoka Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥17.98, compared to a current price of ¥27.12 — trading 50.8% above its estimated fair value. The current EPS (Diluted) is ¥0.09. SiChuan Qian Li Beoka Medical Technology Co's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199), the current EPS (Diluted) is ¥0.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199) Overvalued in 2026?

Based on GuruFocus' analysis, SiChuan Qian Li Beoka Medical Technology Co stock appears to be overvalued. The current stock price of ¥27.12 is trading 50.8% above its estimated GF Value™ of ¥17.98. GuruFocus considers SiChuan Qian Li Beoka Medical Technology Co to be Significantly Overvalued.

Key valuation signals for BJSE:920199:

  • EPS (Diluted): ¥0.09
  • GF Value™: ¥17.98 vs. price of ¥27.12 (50.8% above fair value)
  • GF Score™: 57/100 with 7 warning signs

No single metric tells the full story. See the BJSE:920199 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SiChuan Qian Li Beoka Medical Technology Co Business Description

Address East Third Ring Road, Longtan Industrial Park, Section 2, Chenghua District, Sichuan Province, Chengdu City, CHN, 610052
SiChuan Qian Li Beoka Medical Technology Co Ltd is an intelligent rehabilitation equipment manufacturer integrating research, development, production, sales, and service. Its product series comprises the Electrotherapy series, Heat therapy series, Force therapy series, Spa series, and Oxygen therapy series.
57GF Score

Get the complete analysis for BJSE:920199

EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥27.12
Price
¥17.98
GF Value